Urethrocutaneous fistula after use of Tegress bulking agent: Case report and review of the literature

Authors

  • Anudeep Mukkamala Medical Student Division of Neurourology & Pelvic Reconstructive Surgery University of Michigan, Department of Urology 3875 Taubman Center 1500 East Medical Center Dr. Ann Arbor, MI 48109-5330
  • Jerilyn Latini Adjunct Associate Professor Division of Neurourology & Pelvic Reconstructive Surgery University of Michigan, Department of Urology 3875 Taubman Center 1500 East Medical Center Dr. Ann Arbor, MI 48109-5330
  • Anne Pelletier Cameron Assistant Professor Division of Neurourology & Pelvic Reconstructive Surgery University of Michigan, Department of Urology 3875 Taubman Center 1500 East Medical Center Dr. Ann Arbor, MI 48109-5330

DOI:

https://doi.org/10.5489/cuaj.481

Keywords:

urethrocutaneous fistula, urethral bulking agent, incontinence

Abstract

We report a case of a 68-year-old man who presented with a urethrocutaneous fistula after off-label use of Tegress (C. R. Bard, Inc., Murray Hill, NJ) Urethral Implant for post-prostatectomy incontinence. He was treated for prostate cancer with an open radical retropubic prostatectomy and adjuvant external beam radiation therapy. He was treated unsuccessfully for stress incontinence with a Tegress Urethral Implant and presented to our clinic initially with extrusion of the material urethrally. Four years later he re-presented with a large bullous skin lesion on his suprapubic area. Contrast-enhanced magnetic resonance imaging and retrograde urethral cystogram demonstrated a urethrocutaneous fistula. Subsequent cystoscopy revealed the calcified extruded material in the same location as the site of Tegress injection. The patient underwent simple cystectomy with ileal diversion. He recovered well postoperatively. This appears to be the first reported case of urethrocutaneous fistula after use of a Tegress Urethral Implant for post-prostatectomy stress urinary incontinence.

Downloads

Download data is not yet available.

Downloads

Published

2013-12-05

How to Cite

Mukkamala, A., Latini, J., & Cameron, A. P. (2013). Urethrocutaneous fistula after use of Tegress bulking agent: Case report and review of the literature. Canadian Urological Association Journal, 7(11-12), e833–6. https://doi.org/10.5489/cuaj.481

Issue

Vol. 7 No. 11-12 (2013): CUAJ December

Section

Case Report

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.